SEC Form 4 · accession 0001203311-15-000064
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Nov 17, 2015
Accepted (ET)
Nov 19, 2015 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 17, 2015 | S | 87,473 | $45.3963 | D | 556,115 | D | |
| Common Stock | holding | — | — | — | 27,945 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
- F2Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.